Contact this trialFirst, we need to learn more about you.
ETC-1922159 + Pembrolizumab for Advanced Cancers
Recruiting1 awardPhase 1
Portland, Oregon
This trial is testing a new drug (ETC-1922159) for safety, how well it works, and what the best dose is. The trial has four parts, A-D. Parts A and A Extension have been completed and showed that the drug is safe and had some effect on the disease. In Part B, they will test different doses of the drug to find the best dose, and in Part C they will test the drug in combination with another drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.